Scarica l'app Stockscreener
3.445
3.36%
-0.125
Precedente Chiudi:
$3.57
Aprire:
$3.5
Volume 24 ore:
234.87K
Relative Volume:
0.05
Capitalizzazione di mercato:
$31.90M
Reddito:
$2.09M
Utile/perdita netta:
$-30.04M
Rapporto P/E:
-1.054
EPS:
-3.2685
Flusso di cassa netto:
$-27.57M
1 W Prestazione:
+11.29%
1M Prestazione:
+17.35%
6M Prestazione:
-56.60%
1 anno Prestazione:
-41.23%
Intervallo 1D:
$3.35
$3.54
Intervallo di 1 settimana:
$3.05
$3.9298
Portata 52W:
$2.13
$13.13
Cervomed Inc Stock (CRVO) Company Profile
Nome
Cervomed Inc
Settore
Industria
Telefono
(617) 744-4400
Indirizzo
20 PARK PLAZA, BOSTON
Compare CRVO vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRVO
Cervomed Inc
|
3.445 | 33.05M | 2.09M | -30.04M | -27.57M | -3.2685 |
VRTX
Vertex Pharmaceuticals Inc
|
524.15 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
677.50 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.50 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.17 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.29 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Cervomed Inc Stock (CRVO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-13 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2024-12-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-12-11 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2024-12-11 | Downgrade | Morgan Stanley | Overweight → Underweight |
| 2024-12-10 | Downgrade | D. Boral Capital | Buy → Hold |
| 2024-12-06 | Iniziato | ROTH MKM | Buy |
| 2024-12-05 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-18 | Iniziato | Chardan Capital Markets | Buy |
| 2024-07-26 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-15 | Iniziato | Canaccord Genuity | Buy |
| 2020-11-17 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-03-21 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cervomed Inc Borsa (CRVO) Ultime notizie
CervoMed files prospectus for offer and resale of 10.08M shares - scanx.trade
CRVO Set to Offer 10.08 Million Shares for Sale - GuruFocus
[S-3] CervoMed Inc. Shelf Registration Statement - Stock Titan
CervoMed puts neflamapimod data on DLB in five AAIC talks - Stock Titan
Enterprise value to revenue forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Price to earnings forward of CervoMed Inc. – FWB:DP8 - TradingView
$CervoMed (CRVO.US)$ - Moomoo
Price to book forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Price to book forward of CervoMed Inc. – DUS:DP8 - TradingView
Price to sales forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Enterprise value to EBITDA forward of CervoMed Inc. – NASDAQ:CRVO - TradingView
Enterprise value to EBITDA forward of CervoMed Inc. – DUS:DP8 - TradingView
Enterprise value to revenue forward of CervoMed Inc. – DUS:DP8 - TradingView
CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally - Stocktwits
CervoMed (CRVO) Schedule 13G: Manager-linked 750,000-share holding - Stock Titan
H.C. Wainwright Keeps Their Buy Rating on CervoMed (CRVO) - The Globe and Mail
CRVO stock rockets nearly 100% on patent win before offering news cools rally - MSN
CervoMed Inc. Actuals & Estimates (NASDAQ:CRVO) - TradingView
CRVO Forecast — Price Target — Prediction for 2027 - TradingView
Why did CRVO stock crash 22% in pre-market trading today? - MSN
CervoMed Inc (CRVO) Valuation: PE, PB & Fair Value Analysis - TradingKey
CervoMed Closes $10 Million Stock Offering - Moomoo
CervoMed closes $10 million registered direct offering By Investing.com - Investing.com Nigeria
CervoMed closes $10 million registered direct offering - Investing.com
CervoMed (NASDAQ: CRVO) closes $10M registered direct stock sale - Stock Titan
CervoMed Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - Moomoo
CervoMed Inc. Announces $10 Million Direct Offering of Common Stock and Placement Agent Warrants – June 2026 - Minichart
Form 424B5 CervoMed Inc For: 22 June By Investing.com - Investing.com Nigeria
CervoMed (NASDAQ: CRVO) seeks $10M via 2.5M-share offering; patent allowance noted - Stock Titan
CervoMed Announces $10 Million Registered Direct Offering; Engages H.C. Wainwright - TradingView
CervoMed closes $10M registered direct offering - scanx.trade
CervoMed shares surge after securing US patent protection for dementia therapy (CRVO) - MSN
CervoMed Announces $10 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules - The Manila Times
CRVO Stock Explodes As Insider Buying Fuels Biotech Momentum - timothysykes.com
CervoMed announces $10M registered direct offering priced at-the-market - TipRanks
CervoMed rises on patent news, pares gains after $10M equity sale - TechStock²
CervoMed Reports $10 Million Direct Offering of Shares - Moomoo
CervoMed prices $10M registered direct offering at $4/share By Investing.com - Investing.com India
CervoMed prices $10M registered direct offering at $4/share - Investing.com
CervoMed Announces $10 Million Registered Direct Offering - GlobeNewswire
CervoMed sells 2.5 million shares at $4.00 each to raise $10M - Stock Titan
CervoMed Inc. Receives Patent Allowance for Neflamapimod in Lewy Body Dementia, Securing IP Protection Through 2042 – Minichart - Minichart
CervoMed Shares Surge After Securing U.S. Patent Protection for Dementia Therapy (CRVO) - Yahoo Finance
CRVO Stock Soars As Insider Buy And Cash Raise Extend Runway - StocksToTrade
CRVO Stock Explodes As Insider Buy Fuels Biotech Momentum - timothysykes.com
3 Stocks To Watch Today: CRVO, SPRO, QNRX - RTTNews
CervoMed stock jumps 20% on new U.S. patent allowance By Investing.com - Investing.com Nigeria
Cervomed Inc Azioni (CRVO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cervomed Inc Azioni (CRVO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Winton Matthew | Chief Commercial and Business |
Nov 17 '25 |
Buy |
8.43 |
3,500 |
29,505 |
13,500 |
| Winton Matthew | Chief Commercial and Business |
Nov 18 '25 |
Buy |
7.95 |
1,500 |
11,925 |
15,000 |
| Gregoire Sylvie | Director |
Nov 17 '25 |
Buy |
8.46 |
10,807 |
91,427 |
12,500 |
| Gregoire Sylvie | Director |
Nov 17 '25 |
Buy |
8.46 |
10,793 |
91,309 |
1,484,078 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary |
Nov 18 '25 |
Buy |
8.32 |
2,500 |
20,800 |
12,500 |
| ELDER WILLIAM ROBERT | CFO, GC & Secretary |
Nov 17 '25 |
Buy |
8.45 |
1,000 |
8,450 |
10,000 |
| ALAM JOHN J | CEO & President |
Nov 17 '25 |
Buy |
8.46 |
10,807 |
91,427 |
1,484,078 |
| ALAM JOHN J | CEO & President |
Nov 17 '25 |
Buy |
8.46 |
10,793 |
91,309 |
12,500 |
| Gregoire Sylvie | Director |
Nov 13 '25 |
Buy |
7.51 |
4,447 |
33,397 |
1,471,578 |
| Gregoire Sylvie | Director |
Nov 14 '25 |
Buy |
7.57 |
1,707 |
12,922 |
1,473,285 |
0.86%
3.14%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):